A fungal infection solution could help eliminate up to 86% of malaria-carrying mosquitoes, offering a powerful new tool in ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

Ghyslain Mombo-Ngoma, MD, PhD, led a study in Gabon in which researchers gave a single-dose treatment combining an ...

Explore Laveran's groundbreaking discovery of the malaria parasite and its lasting impact on infectious disease research and ...

Sokoto State confirms 8 cases of Dengue fever, activating heightened surveillance and urging health workers to maintain a ...

Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

Switzerland-based Novartis has developed a new anti-malaria drug, GanLum, that showed 97% effectiveness in late-stage trials.

A new anti- malaria drug with a cure rate of over 97 per cent has been developed by scientists. The drug is the first to be ...

For many Gabonese, malaria remains a constant struggle. Libreville resident Julicia Nfono says the disease keeps coming back ...

Sokoto State has confirmed an outbreak of Dengue Fever, reporting eight laboratory-verified cases across Sokoto metropolis, ...